Last reviewed · How we verify
PanChol
At a glance
| Generic name | PanChol |
|---|---|
| Sponsor | Centre for Infectious Disease Research in Zambia |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers (PHASE1)
- First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PanChol CI brief — competitive landscape report
- PanChol updates RSS · CI watch RSS
- Centre for Infectious Disease Research in Zambia portfolio CI